泽璟制药-U
(688266)
| 流通市值：283.77亿 | | | 总市值：283.77亿 |
| 流通股本：2.65亿 | | | 总股本：2.65亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,117,480,591.46 | 2,102,866,553.5 | 2,153,678,920.77 | 2,134,543,569.13 |
| 交易性金融资产 | 33,972,692.65 | 33,697,125.44 | 40,500,717.3 | 69,069,502.42 |
| 应收票据及应收账款 | 175,399,720.05 | 137,742,821.24 | 143,628,405.6 | 132,638,815.48 |
| 其中：应收票据 | - | 324,131.6 | 324,131.6 | - |
| 应收账款 | 175,399,720.05 | 137,418,689.64 | 143,304,274 | 132,638,815.48 |
| 预付款项 | 47,256,101.22 | 40,584,719.96 | 41,281,442.35 | 56,167,118.21 |
| 其他应收款合计 | 9,741,045.61 | 9,621,709.34 | 9,380,983.92 | 9,531,046.62 |
| 存货 | 164,215,169.54 | 167,491,327.54 | 182,861,135.29 | 160,289,459.88 |
| 其他流动资产 | 3,563,748.87 | 4,556,024.47 | 4,567,204.57 | 3,004,080.8 |
| 流动资产合计 | 2,551,629,069.4 | 2,496,560,281.49 | 2,575,898,809.8 | 2,565,243,592.54 |
| 非流动资产: | | | | |
| 其他权益工具投资 | - | - | - | 5,987,768.53 |
| 固定资产 | 194,457,164.6 | 199,387,144.12 | 205,300,520.51 | 195,613,234.99 |
| 在建工程 | 152,531,961.67 | 127,053,501.11 | 123,471,414.28 | 74,906,160.45 |
| 使用权资产 | 19,141,912.99 | 25,167,656.2 | 34,655,845.75 | 37,045,286.83 |
| 无形资产 | 40,178,060.57 | 45,097,791.62 | 50,010,842.64 | 54,142,400.64 |
| 长期待摊费用 | 8,739,853.31 | 10,231,304.37 | 11,393,549.07 | 27,036,524.79 |
| 其他非流动资产 | 32,525,329.5 | 14,326,202 | 3,883,301.93 | 7,172,941.23 |
| 非流动资产合计 | 447,574,282.64 | 421,263,599.42 | 428,715,474.18 | 401,904,317.46 |
| 资产总计 | 2,999,203,352.04 | 2,917,823,880.91 | 3,004,614,283.98 | 2,967,147,910 |
| 流动负债: | | | | |
| 短期借款 | 976,363,228.04 | 881,534,044.49 | 951,861,764.88 | 882,215,559.32 |
| 应付票据及应付账款 | 195,242,184.05 | 201,586,659.57 | 197,103,446.9 | 152,642,391.77 |
| 其中：应付票据 | 17,637,650 | 18,067,154.8 | 10,208,204.8 | 4,498,500 |
| 应付账款 | 177,604,534.05 | 183,519,504.77 | 186,895,242.1 | 148,143,891.77 |
| 预收款项 | - | - | 15,290.52 | 38,226.3 |
| 合同负债 | 524,982.09 | 273,558.2 | - | - |
| 应付职工薪酬 | 66,171,395.63 | 46,444,944.33 | 68,504,827.25 | 56,082,939.06 |
| 应交税费 | 35,088,475.5 | 36,620,178.49 | 33,445,688.39 | 34,369,359.77 |
| 其他应付款合计 | 45,457,064.72 | 109,082,718.93 | 106,347,910.54 | 177,017,708.57 |
| 一年内到期的非流动负债 | 23,376,316.37 | 49,939,460.63 | 16,166,597.35 | 11,310,603.39 |
| 流动负债合计 | 1,342,223,646.4 | 1,325,481,564.64 | 1,373,445,525.83 | 1,313,676,788.18 |
| 非流动负债: | | | | |
| 长期借款 | 125,699,999.96 | 59,812,578.75 | 44,350,969.43 | - |
| 租赁负债 | 13,140,162.19 | 13,073,221.81 | 26,861,235.3 | 29,539,566.44 |
| 递延收益 | 7,661,566.09 | 8,019,159.7 | 9,201,753.31 | 12,700,103.68 |
| 递延所得税负债 | 3,673,860.67 | 4,688,624.66 | 5,701,419.8 | 6,538,660.02 |
| 其他非流动负债 | 330,188,680.29 | 283,018,868.95 | 292,452,831.19 | 301,886,793.43 |
| 非流动负债合计 | 480,364,269.2 | 368,612,453.87 | 378,568,209.03 | 350,665,123.57 |
| 负债合计 | 1,822,587,915.6 | 1,694,094,018.51 | 1,752,013,734.86 | 1,664,341,911.75 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 264,708,186 | 264,708,186 | 264,708,186 | 264,708,186 |
| 资本公积 | 3,116,344,427.97 | 3,120,645,068.74 | 3,120,366,607.65 | 3,097,275,094.65 |
| 其他综合收益 | -14,891,154.47 | -14,335,489.01 | -14,474,378.1 | 18,218,907.37 |
| 未分配利润 | -2,189,546,023.06 | -2,145,004,719.2 | -2,116,742,484.07 | -2,076,814,691.77 |
| 归属于母公司股东权益合计 | 1,176,615,436.44 | 1,226,013,046.53 | 1,253,857,931.48 | 1,303,387,496.25 |
| 少数股东权益 | - | -2,283,184.13 | -1,257,382.36 | -581,498 |
| 股东权益合计 | 1,176,615,436.44 | 1,223,729,862.4 | 1,252,600,549.12 | 1,302,805,998.25 |
| 负债和股东权益合计 | 2,999,203,352.04 | 2,917,823,880.91 | 3,004,614,283.98 | 2,967,147,910 |
| 公告日期 | 2025-08-23 | 2025-04-19 | 2025-04-19 | 2024-10-26 |
| 审计意见(境内) | | | 标准无保留意见 | |